ContextVision: ‘Large and Exciting’ Things On The Horizon
Recently large and exciting decisions have been made at ContextVision.
From now on, [they] will focus our pathology business entirely on the establishment of an AI based pathology lab service, and are now in the process of moving the decision support tools, including INIFY Prostate to a wholly-owned subsidiary, INIFY Laboratories.
The updated strategy means that INIFY Laboratories will continue to develop machine learning technology for our own laboratory service, and let go of the present business strategy of developing and selling decision support tools to external laboratories. This means INIFY Prostate will not be available for sale to other pathology labs in Europe or elsewhere. Instead, it will be integrated as a vital part in the pathology lab service.
See:
INIFY Laboratories AB becomes an independent company • ContextVision
